138 related articles for article (PubMed ID: 28763347)
1. Ex Vivo Induction of Multiple Myeloma-specific Immune Responses by Monocyte-derived Dendritic Cells Following Stimulation by Whole-tumor Antigen of Autologous Myeloma Cells.
Vasileiou S; Baltadakis I; Delimpasi S; Karatza MH; Liapis K; Garofalaki M; Tziotziou E; Poulopoulou Z; Karakasis D; Harhalakis N
J Immunother; 2017 Sep; 40(7):253-264. PubMed ID: 28763347
[TBL] [Abstract][Full Text] [Related]
2. Successful cross-presentation of allogeneic myeloma cells by autologous alpha-type 1-polarized dendritic cells as an effective tumor antigen in myeloma patients with matched monoclonal immunoglobulins.
Yang DH; Kim MH; Lee YK; Hong CY; Lee HJ; Nguyen-Pham TN; Bae SY; Ahn JS; Kim YK; Chung IJ; Kim HJ; Kalinski P; Lee JJ
Ann Hematol; 2011 Dec; 90(12):1419-26. PubMed ID: 21465188
[TBL] [Abstract][Full Text] [Related]
3. Generation of myeloma-specific T cells using dendritic cells loaded with MUC1- and hTERT- drived nonapeptides or myeloma cell apoptotic bodies.
Ocadlikova D; Kryukov F; Mollova K; Kovarova L; Buresdova I; Matejkova E; Penka M; Buchler T; Hajek R; Michalek J
Neoplasma; 2010; 57(5):455-64. PubMed ID: 20568900
[TBL] [Abstract][Full Text] [Related]
4. Induction of myeloma-specific cytotoxic T cells using dendritic cells transfected with tumor-derived RNA.
Milazzo C; Reichardt VL; Müller MR; Grünebach F; Brossart P
Blood; 2003 Feb; 101(3):977-82. PubMed ID: 12393470
[TBL] [Abstract][Full Text] [Related]
5. CD11c+ blood dendritic cells induce antigen-specific cytotoxic T lymphocytes with similar efficiency compared to monocyte-derived dendritic cells despite higher levels of MHC class I expression.
Radford KJ; Turtle CJ; Kassianos AJ; Hart DN
J Immunother; 2006; 29(6):596-605. PubMed ID: 17063122
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J
J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810
[TBL] [Abstract][Full Text] [Related]
7. Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients.
de Vries IJ; Lesterhuis WJ; Scharenborg NM; Engelen LP; Ruiter DJ; Gerritsen MJ; Croockewit S; Britten CM; Torensma R; Adema GJ; Figdor CG; Punt CJ
Clin Cancer Res; 2003 Nov; 9(14):5091-100. PubMed ID: 14613986
[TBL] [Abstract][Full Text] [Related]
8. Production of myeloid dendritic cells (DC) pulsed with tumor-specific idiotype protein for vaccination of patients with multiple myeloma.
Guardino AE; Rajapaksa R; Ong KH; Sheehan K; Levy R
Cytotherapy; 2006; 8(3):277-89. PubMed ID: 16793736
[TBL] [Abstract][Full Text] [Related]
9. Individual myeloma-specific T-cell clones eliminate tumour cells and correlate with clinical outcomes in patients with multiple myeloma.
Michalek J; Ocadlikova D; Matejkova E; Foltankova V; Dudová S; Slaby O; Horvath R; Pour L; Hajek R
Br J Haematol; 2010 Mar; 148(6):859-67. PubMed ID: 20067568
[TBL] [Abstract][Full Text] [Related]
10. Alpha-type 1-polarized dendritic cells loaded with apoptotic allogeneic myeloma cell line induce strong CTL responses against autologous myeloma cells.
Yang DH; Kim MH; Hong CY; Lee YK; Jin CJ; Pham TN; Ahn JS; Bae WK; Kim YK; Chung IJ; Kim HJ; Kalinski P; Lee JJ
Ann Hematol; 2010 Aug; 89(8):795-801. PubMed ID: 20238114
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo induction of multiple myeloma-specific cytotoxic T lymphocytes.
Hayashi T; Hideshima T; Akiyama M; Raje N; Richardson P; Chauhan D; Anderson KC
Blood; 2003 Aug; 102(4):1435-42. PubMed ID: 12714512
[TBL] [Abstract][Full Text] [Related]
12. FastDC derived from human monocytes within 48 h effectively prime tumor antigen-specific cytotoxic T cells.
Dauer M; Schad K; Herten J; Junkmann J; Bauer C; Kiefl R; Endres S; Eigler A
J Immunol Methods; 2005 Jul; 302(1-2):145-55. PubMed ID: 15992809
[TBL] [Abstract][Full Text] [Related]
13. PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine.
Rosenblatt J; Glotzbecker B; Mills H; Vasir B; Tzachanis D; Levine JD; Joyce RM; Wellenstein K; Keefe W; Schickler M; Rotem-Yehudar R; Kufe D; Avigan D
J Immunother; 2011 Jun; 34(5):409-18. PubMed ID: 21577144
[TBL] [Abstract][Full Text] [Related]
14. Idiotype vaccination of multiple myeloma patients using monocyte-derived dendritic cells.
Reichardt VL; Milazzo C; Brugger W; Einsele H; Kanz L; Brossart P
Haematologica; 2003 Oct; 88(10):1139-49. PubMed ID: 14555310
[TBL] [Abstract][Full Text] [Related]
15. Synergistic Antimyeloma Activity of Dendritic Cells and Pomalidomide in a Murine Myeloma Model.
Vo MC; Yang S; Jung SH; Chu TH; Lee HJ; Lakshmi TJ; Park HS; Kim HJ; Lee JJ
Front Immunol; 2018; 9():1798. PubMed ID: 30123221
[TBL] [Abstract][Full Text] [Related]
16. Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients.
Bonehill A; Van Nuffel AM; Corthals J; Tuyaerts S; Heirman C; François V; Colau D; van der Bruggen P; Neyns B; Thielemans K
Clin Cancer Res; 2009 May; 15(10):3366-75. PubMed ID: 19417017
[TBL] [Abstract][Full Text] [Related]
17. Electroporation of dendritic cells with autologous total RNA from tumor material.
Milano F; Krishnadath KK
Methods Mol Biol; 2014; 1139():87-95. PubMed ID: 24619673
[TBL] [Abstract][Full Text] [Related]
18. Induction of multiple myeloma-specific cytotoxic T lymphocyte stimulation by dendritic cell pulsing with purified and optimized myeloma cell lysates.
Lee JJ; Choi BH; Kang HK; Park MS; Park JS; Kim SK; Pham TN; Cho D; Nam JH; Kim YJ; Rhee JH; Yang DH; Kim YK; Kim HJ; Chung IJ
Leuk Lymphoma; 2007 Oct; 48(10):2022-31. PubMed ID: 17917970
[TBL] [Abstract][Full Text] [Related]
19. Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96.
Qian J; Wang S; Yang J; Xie J; Lin P; Freeman ME; Yi Q
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8808-15. PubMed ID: 16361569
[TBL] [Abstract][Full Text] [Related]
20. Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells.
Wen YJ; Barlogie B; Yi Q
Blood; 2001 Mar; 97(6):1750-5. PubMed ID: 11238117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]